Identification of atherosclerosis-modifying genes: Pathogenic insights and therapeutic potential

Expert Review of Cardiovascular Therapy

Volumn 4, Issue 5, 2006, Pages 703-709

  Smith, Jonathan D ^a   Topol, Eric J ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association study; Atherosclerosis; Genetics; Linkage; Quantitative trait locus mapping

Indexed keywords

APOLIPOPROTEIN E; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOCARDIOGRAPHY; BEHAVIOR MODIFICATION; CLINICAL ASSESSMENT; CORONARY ARTERY ATHEROSCLEROSIS; DNA MODIFICATION; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; NONHUMAN; PATHOGENESIS; PATIENT COUNSELING; PHENOTYPE; PREDICTION; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ATHEROSCLEROSIS; CHROMOSOME MAPPING; CORONARY ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOMICS; HUMANS; LINKAGE (GENETICS); QUANTITATIVE TRAIT LOCI; VARIATION (GENETICS);

EID: 33750933937     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.4.5.703     Document Type: Review

References (36)

1. Helgadottir A, Manolescu A, Thorleifsson G et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233-239 (2004).
2. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578-1581 (2003).
3. Weng L, Kavaslar N, Ustaszewska A et al. Lack of MEF2A mutations in coronary artery disease. J. Clin. Invest. 115, 1016-1020 (2005).
4. Bhagavatula MR, Fan C, Shen GQ et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13, 3181-3188 (2004).
5. Gonzalez P. Garcia-Castro M, Reguero JR et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J. Med. Genet. 43, 167-169 (2006).
6. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat. Genet. 29, 306-309 (2001).
7. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 141, 137-147 (2004).
8. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654 (2002).
9. Yamada A, Ichihara S, Murase Y et al. Lack of association of polymorphisms of the lymphotoxin-α gene with myocardial infarction in Japanese. J. Mol. Med. 82, 477-483 (2004).
10. Smith JD. Mouse models of atherosclerosis. Lab. Anim. Sci. 48, 573-579 (1998).
11. Rosenfeld ME, Polinsky P, Virmani R et al. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler. Thromb. Vasc. Biol. 20, 2587-2592 (2000).
12. Smith JD, Trogan E, Ginsberg M et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl Acad. Sci. USA 92, 8264-8268 (1995).
13. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95, 858-866 (2004).
14. Dansky HM, Barlow CB, Lominska C et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vase. Biol. 21, 1662-1667 (2001).
15. Wang X, Ria M, Kelmenson PM et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37, 365-372 (2005).
16. Mehrabian M, Allayee H, Wong J et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91, 120-126 (2002).
17. Vitt U, Gietzen D, Stevens K et al. Identification of candidate disease genes by EST alignments, synteny, and expression and verification of Ensembl genes on rat chromosome 1q43-54. Genome Res. 14, 640-650 (2004).
18. Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am. J. Hum. Genet. 77, 1-15 (2005).
19. Pajukanta P, Cargill M, Viitanen L et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early-and late-settlement populations of Finland. Am J. Hum. Genet. 67, 1481-1493 (2000).
20. Francke S, Manraj M, Lacquemant C et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet 10, 2751-2765 (2001).
21. Broeckel U, Hengstenberg C, Mayer B et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210-214 (2002).
22. Harrap SB, Zammit KS, Wong ZY et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22, 874-878 (2002).
23. Wang Q, Rao S, Shen GQ et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74, 262-271 (2004).
24. Hauser ER, Crossman DC, Granger CB et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75, 436-447 (2004).
25. Samani NJ, Burton P, Mangino M et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77, 1011-1020 (2005).
26. Phelan SA, Beier DR, Higgins DC, Paigen B. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on chromosome 1. Mamm. Genome 13, 548-553 (2002).
27. Stewart-Phillips JL, Lough J, Skamene E. ATH-3, a new gene for atherosclerosis in the mouse. Clin. Invest. Med. 12, 121-126 (1989).
28. Purcell MK, Mu JL, Higgins DC et al. Fine mapping of Ath6, a quantitative trait locus for atherosclerosis in mice. Mamm. Genome 12, 495-500 (2001).
29. Korstanje R, Eriksson P, Samnegard A et al. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis 177, 443-450 (2004).
30. Dansky HM, Shu P, Donavan M et al. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160, 1599-1608 (2002).
31. Ishimori N, Li R, Kelmenson PM et al. Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/SvImJ. Arterioscler. Thromb. Vasc. Biol. 24, 161-166 (2004).
32. Smith JD, Bhasin JM, Baglione J et al. Atherosclerosis susceptibility loci identified from a strain intercross of apolipoprotein E-deficient mice via a high-density genome scan. Arterioscler. Thromb. Vasc. Biol. 26, 597-603 (2006).
33. Su Z, Li Y, James JC et al. Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene. Genetics 172, 1799-1807 (2006).
34. Seidelmann SB, De LC, Leibel RL et al. Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4. Arterioscler. Thromb. Vasc. Biol. 25, 204-210 (2005).
35. Welch CL, Bretschger S, Latib N et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ld1r knockout mouse model. Proc. Natl Acad. Sci. USA 98, 7946-7951 (2001).
36. -/- mice. Proc. Natl. Acad. Sci. USA 103, 123-128 (2006).